AB-207 is under clinical development by Angiocrine Bioscience and currently in Phase I for Anal Fissure. According to GlobalData, Phase I drugs for Anal Fissure does not have sufficient historical ...
While occasional burning after a bowel movement is generally not a cause for concern frequent discomfort should not be ignored Read ahead ...